Terveystalo (TTALO) Jefferies London Healthcare Conference 2024 summary
Event summary combining transcript, slides, and related documents.
Jefferies London Healthcare Conference 2024 summary
3 Feb, 2026Business overview and market position
Leading Nordic healthcare platform with €1.3 billion revenue, focused on private outpatient services.
Operates over 300 units in Finland and 150 in Sweden, with growing digital presence.
61% of revenue from corporate clients, 30% from consumers, and 9% from public sector.
Integrated care model offers fast, 24/7 access to both digital and physical services.
15,000 professionals serve 1.2 million customers, mainly in Finland.
Financial performance and turnaround
EBITDA margin improved from below 8% to 12.3% over 24 months, surpassing targets.
Achieved profitability and growth despite negative consumer and corporate confidence in Finland.
Turnaround driven by commercial actions, productivity boosts, and cost cutting.
No market segment provided external growth boost; all improvements were internal.
Future focus shifts from turnaround to organic growth and technology investment.
Strategic direction and growth drivers
Ongoing investments in digital integration and AI-driven applications to enhance efficiency.
Customer satisfaction and medical quality KPIs at all-time highs.
Positioned to benefit from widening public funding and productivity gaps in healthcare.
Demographic trends and rising service prices support long-term market growth.
Scalable, digital-driven business model with strong cash flow for reinvestment and shareholder rewards.
Latest events from Terveystalo
- Revenue and profit fell amid weak demand, but acquisitions and cost actions support future growth.TTALO
Q2 2026 - Acquisition forms a leading European outpatient care platform with strong synergies and EPS growth.TTALO
M&A announcement - €574 million deal forms Finland’s top eye health group, targeting €11–15M annual synergies.TTALO
M&A announcement - Revenue and profit dropped sharply, but digitalization and efficiency support gradual H2 recovery.TTALO
Q1 2026 - Profitability hit record highs despite lower revenue, with 2026 outlook cautious but optimistic.TTALO
Q4 2025 - Record profitability enables digital-driven growth and ambitious financial targets across business areas.TTALO
CMD 2024 - Record Q3 earnings and margin gains set the stage for a new growth-focused phase.TTALO
Q3 2024 - Record Q2 with 5.5% revenue growth, 49.1% EBITA increase, and raised 2024 margin guidance.TTALO
Q2 2024 - Strong growth and profitability in 2024, with improved margins and positive 2025 outlook.TTALO
Q4 2024